Ajanta Pharma launches Clonidine Hydrochloride ER tablet in USA
Ajanta Pharma received US FDA approval and has launched Clonidine Hydrochloride Extended Release Tablets in the US Market through its wholly owned subsidiary Ajanta Pharma […]
Ajanta
Ajanta Pharma launches eletriptan hydrobromide in USA
Ajanta Pharma has launched eletriptan hydrobromide tablets in the US market. The drug is a bioequivalent generic version of Relpax tablets and the company has […]
Ajanta Pharma receives USFDA approval for Entacapone
Ajanta Pharma has received final USFDA approval for Entacapone tablets to market the same in USA. It is a bioequivalent generic version of Comtan tablets. […]
Ajanta Pharma receives USFDA approval for Almotriptan Malate tablet
Ajanta Pharma has received final USFDA approval for its generic version of acute migraine pain relief drug almotriptan malate tablets . The company will produce […]
Ajanta Pharma receives final approval for Monelukast
Ajanta Pharma has received final approval for its three ANDAs (Abbreviated New Drug Application) by USFDA for Montelukast tablets in the strength of 10 mg, […]